The global multiomics market size is calculated at US$ 2.76 in 2024, grew to US$ 3.18 billion in 2025, and is projected to reach around US$ 11.46 billion by 2034. The market is expanding at a CAGR of 15.32% between 2024 and 2034.
In October 2024, a strategic alliance was established between Singleton Biotechnologies, a pioneer in single-cell multi-omics solutions, and Bioscreen, a well-known distributor of cutting-edge life science products in India. This deal would make Bioscreen the only distributor of Singleron's state-of-the-art single-cell multi-omics products in India.